These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 16319329

  • 1. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD.
    Bhowmik A, Seemungal TA, Donaldson GC, Wedzicha JA.
    Eur Respir J; 2005 Dec; 26(6):1009-15. PubMed ID: 16319329
    [Abstract] [Full Text] [Related]

  • 2. Exhaled nitric oxide from lung periphery is increased in COPD.
    Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA.
    Eur Respir J; 2005 Jul; 26(1):52-9. PubMed ID: 15994389
    [Abstract] [Full Text] [Related]

  • 3. [Concentration of nitric oxide exhaled air (eNO) in patients with COPD and bronchiectasis].
    Ziora D, Kałuska K, Rauer R, Kozielski J.
    Pneumonol Alergol Pol; 2003 Jul; 71(9-10):418-27. PubMed ID: 15052978
    [Abstract] [Full Text] [Related]

  • 4. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 5. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease.
    McCurdy MR, Sharafkhaneh A, Abdel-Monem H, Rojo J, Tittel FK.
    J Breath Res; 2011 Mar; 5(1):016003. PubMed ID: 21378438
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL.
    Am J Respir Crit Care Med; 2006 May 15; 173(10):1114-21. PubMed ID: 16484677
    [Abstract] [Full Text] [Related]

  • 9. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function.
    Ansarin K, Chatkin JM, Ferreira IM, Gutierrez CA, Zamel N, Chapman KR.
    Eur Respir J; 2001 May 15; 17(5):934-8. PubMed ID: 11488329
    [Abstract] [Full Text] [Related]

  • 10. [The effect of asthma and COPD exacerbation on exhaled nitric oxide (FE(NO))].
    Maskey-Warzechowska M, Przybyłowski T, Hildebrand K, Kumor M, Górska K, Fangrat A, Kucińska J, Kościuch J, Chazan R.
    Pneumonol Alergol Pol; 2004 May 15; 72(5-6):181-6. PubMed ID: 15757255
    [Abstract] [Full Text] [Related]

  • 11. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children.
    Lanz MJ, Leung DY, White CW.
    Ann Allergy Asthma Immunol; 1999 Feb 15; 82(2):161-4. PubMed ID: 10071519
    [Abstract] [Full Text] [Related]

  • 12. Exhaled nitric oxide in chronic obstructive pulmonary disease.
    Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1998 Mar 15; 157(3 Pt 1):998-1002. PubMed ID: 9517624
    [Abstract] [Full Text] [Related]

  • 13. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A.
    Respir Med; 2005 Jul 15; 99(7):816-24. PubMed ID: 15939243
    [Abstract] [Full Text] [Related]

  • 14. An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis.
    Ziora D, Kaluska K, Kozielski J.
    Eur Respir J; 2004 Oct 15; 24(4):609-14. PubMed ID: 15459140
    [Abstract] [Full Text] [Related]

  • 15. Exhaled hydrogen sulfide in patients with chronic obstructive pulmonary disease and its correlation with exhaled nitric oxide.
    Sun Y, Wang XM, Chen YH, Zhu RX, Liao CC.
    Chin Med J (Engl); 2013 Oct 15; 126(17):3240-4. PubMed ID: 24033943
    [Abstract] [Full Text] [Related]

  • 16. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.
    Antus B, Barta I, Kullmann T, Lazar Z, Valyon M, Horvath I, Csiszer E.
    Am J Respir Crit Care Med; 2010 Dec 15; 182(12):1492-7. PubMed ID: 20656939
    [Abstract] [Full Text] [Related]

  • 17. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.
    Bazeghi N, Gerds TA, Budtz-Jørgensen E, Hove J, Vestbo J.
    Respir Med; 2011 Sep 15; 105(9):1338-44. PubMed ID: 21530214
    [Abstract] [Full Text] [Related]

  • 18. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase.
    Gabbay E, Walters EH, Orsida B, Whitford H, Ward C, Kotsimbos TC, Snell GI, Williams TJ.
    Am J Respir Crit Care Med; 2000 Dec 15; 162(6):2182-7. PubMed ID: 11112135
    [Abstract] [Full Text] [Related]

  • 19. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease.
    Agustí AG, Villaverde JM, Togores B, Bosch M.
    Eur Respir J; 1999 Sep 15; 14(3):523-8. PubMed ID: 10543270
    [Abstract] [Full Text] [Related]

  • 20. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD.
    Chou KT, Su KC, Huang SF, Hsiao YH, Tseng CM, Su VY, Hung SC, Perng DW.
    Lung; 2014 Aug 15; 192(4):499-504. PubMed ID: 24816967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.